Wyart Elisabeth, Carrà Giovanna, Angelino Elia, Penna Fabio, Porporato Paolo E
Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center 'Guido Tarone', University of Torino, 10126 Torino, Italy.
San Luigi Gonzaga Hospital, Orbassano, Italy; Department of Clinical and Biological Science, University of Torino, Orbassano, Italy.
Trends Endocrinol Metab. 2025 Jan 4. doi: 10.1016/j.tem.2024.12.005.
Cachexia is a complex metabolic disorder characterized by negative energy balance due to increased consumption and lowered intake, leading to progressive tissue wasting and inefficient energy distribution. Once considered as passive bystander, metabolism is now acknowledged as a regulator of biological functions and disease progression. This shift in perspective mirrors the evolving understanding of cachexia itself, no longer viewed merely as a secondary consequence of cancer but as an active process. However, metabolic dysregulations in cachexia are currently studied in an organ-specific manner, failing to be fully integrated into a comprehensive framework that explains their functional roles in disease progression. Thus, in this review, we aim to provide a general overview of the various metabolic alterations with a potential systemic impact.
恶病质是一种复杂的代谢紊乱,其特征是由于消耗增加和摄入减少导致能量负平衡,进而导致进行性组织消耗和能量分配效率低下。代谢曾被视为被动旁观者,如今已被公认为生物功能和疾病进展的调节因子。这种观念的转变反映了对恶病质本身认识的不断演变,恶病质不再仅仅被视为癌症的次要后果,而是一个活跃的过程。然而,目前对恶病质中代谢失调的研究是以器官特异性方式进行的,未能完全整合到一个解释其在疾病进展中功能作用的综合框架中。因此,在本综述中,我们旨在对具有潜在全身影响的各种代谢改变进行概述。